Rudiger Klapdor

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Journal: Scientific reports

Published: May 15, 2026

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Journal: Geburtshilfe und Frauenheilkunde

Published: February 03, 2026

Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.

Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.

Journal: Oncoimmunology

Published: September 17, 2025

Induction of Labor with Oral Misoprostol - Effectiveness and Safety of Low-dose vs. High-dose Regimens.

Induction of Labor with Oral Misoprostol - Effectiveness and Safety of Low-dose vs. High-dose Regimens.

Journal: Geburtshilfe und Frauenheilkunde

Published: May 20, 2025

Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.

Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.

Journal: Gynecologic oncology

Published: March 12, 2025

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Journal: Frontiers in immunology

Published: February 05, 2025

Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.

Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.

Journal: International journal of molecular sciences

Published: January 31, 2025

Postpartum hemorrhage: risk factors for severe blood loss, surgical intervention and peripartum hysterectomy.

Postpartum hemorrhage: risk factors for severe blood loss, surgical intervention and peripartum hysterectomy.

Journal: Archives of gynecology and obstetrics

Published: December 29, 2024

Adhesion Prevention in Gynecologic Surgery: Guidance and Clinical Experience.

Adhesion Prevention in Gynecologic Surgery: Guidance and Clinical Experience.

Journal: Journal of clinical medicine

Published: October 29, 2024

Sentinel Lymphonodectomy in Early Vulvar Cancer in Daily Practice: a Multicenter Experience from Germany.

Sentinel Lymphonodectomy in Early Vulvar Cancer in Daily Practice: a Multicenter Experience from Germany.

Journal: Geburtshilfe und Frauenheilkunde

Published: October 24, 2024

Effect of mother's active pushing at cesarean delivery: a randomized controlled trial.

Effect of mother's active pushing at cesarean delivery: a randomized controlled trial.

Journal: Archives of gynecology and obstetrics

Published: September 25, 2024

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Journal: Frontiers in immunology

Published: August 23, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026